Solara Active Pharma Sciences Ltd
NSE:SOLARA

Watchlist Manager
Solara Active Pharma Sciences Ltd Logo
Solara Active Pharma Sciences Ltd
NSE:SOLARA
Watchlist
Price: 660.25 INR 0.14% Market Closed
Market Cap: 31.7B INR
Have any thoughts about
Solara Active Pharma Sciences Ltd?
Write Note

Solara Active Pharma Sciences Ltd
EPS (Diluted)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Solara Active Pharma Sciences Ltd
EPS (Diluted) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company EPS (Diluted) CAGR 3Y CAGR 5Y CAGR 10Y
Solara Active Pharma Sciences Ltd
NSE:SOLARA
EPS (Diluted)
-â‚ą148
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
EPS (Diluted)
â‚ą64
CAGR 3-Years
-18%
CAGR 5-Years
-17%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
EPS (Diluted)
â‚ą55
CAGR 3-Years
20%
CAGR 5-Years
22%
CAGR 10-Years
15%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
EPS (Diluted)
â‚ą46
CAGR 3-Years
21%
CAGR 5-Years
21%
CAGR 10-Years
4%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
EPS (Diluted)
â‚ą53
CAGR 3-Years
12%
CAGR 5-Years
26%
CAGR 10-Years
8%
M
Mankind Pharma Ltd
NSE:MANKIND
EPS (Diluted)
â‚ą47
CAGR 3-Years
15%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Solara Active Pharma Sciences Ltd
Glance View

Market Cap
31.7B INR
Industry
Pharmaceuticals

Solara Active Pharma Sciences Ltd. engages in the manufacture and development of active pharmaceutical ingredient. The company is headquartered in Chennai, Tamil Nadu. The company went IPO on 2018-06-27. The firm is involved in contract manufacturing and development services for global companies. Its commercial products include Aprepitant (Antiemetic), Brivaracetam (Antiepileptic), Bumetanide (Inj) (Loop Diuretic), Buspirone Hcl (Anxiolytic), Cevimeline Hydrochloride (Muscarinic Agonist), Cinacalcet Hydrochloride (Calcimimetic Agent), Citicoline Sodium (Anticonvulsant), Colchicine (Antigout Agent), Disulfiram (Chronic Alcoholism), Edaravone (Recovery Of Stroke), Etomidate (Anesthetics), Felbamate (Anticonvulsant), Flecainide Acetate (Anti-Arrhythmic Agent), Rifaximin (Antibiotic), S-Ibuprofen (Anti-Inflammatory), Oseltamivir Phosphate(Antiviral) and Levetiracetam (Anticonvulsant). The company provides services, such as synthetic development, analytical development, process engineering, and regulatory services.

SOLARA Intrinsic Value
588.77 INR
Overvaluation 11%
Intrinsic Value
Price

See Also

What is Solara Active Pharma Sciences Ltd's EPS (Diluted)?
EPS (Diluted)
-148.9 INR

Based on the financial report for Sep 30, 2024, Solara Active Pharma Sciences Ltd's EPS (Diluted) amounts to -148.9 INR.

What is Solara Active Pharma Sciences Ltd's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 1Y
-1 690%

Over the last year, the EPS (Diluted) growth was -1 690%.

Back to Top